1 – 2 of 2
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Dermcidin exerts its oncogenic effects in breast cancer via modulation of ERBB signaling
(
- Contribution to journal › Article
- 2013
-
Mark
BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition
(
- Contribution to journal › Article